These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
643 related articles for article (PubMed ID: 25784374)
21. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? Walton Diaz A; Hoang AN; Turkbey B; Hong CW; Truong H; Sterling T; Rais-Bahrami S; Siddiqui MM; Stamatakis L; Vourganti S; Nix J; Logan J; Harris C; Weintraub M; Chua C; Merino MJ; Choyke P; Wood BJ; Pinto PA J Urol; 2013 Dec; 190(6):2020-2025. PubMed ID: 23792130 [TBL] [Abstract][Full Text] [Related]
22. Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS Trial. Lovegrove CE; Miah S; El-Shater Bosaily A; Bott S; Brown L; Burns-Cox N; Dudderidge T; Freeman A; Henderson A; Hindley R; Kaplan R; Kirkham A; Oldroyd R; Parker C; Persad R; Punwani S; Rosario D; Shergill I; Winkler M; Emberton M; Ahmed HU J Urol; 2020 Jan; 203(1):100-107. PubMed ID: 31335254 [TBL] [Abstract][Full Text] [Related]
23. How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy? Song G; Ruan M; Wang H; Fan Y; He Q; Lin Z; Li X; Li P; Wang X; He Z; Zhou L J Urol; 2020 Dec; 204(6):1202-1208. PubMed ID: 32716686 [TBL] [Abstract][Full Text] [Related]
24. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772 [TBL] [Abstract][Full Text] [Related]
25. Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies. Rodríguez Socarrás ME; Gomez Rivas J; Cuadros Rivera V; Reinoso Elbers J; Llanes González L; Michel Mercado I; Fernandez Del Alamo J; Juarez Del Dago P; Sancha FG J Urol; 2020 Oct; 204(4):726-733. PubMed ID: 32314932 [TBL] [Abstract][Full Text] [Related]
26. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years. Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090 [TBL] [Abstract][Full Text] [Related]
27. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies. Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274 [TBL] [Abstract][Full Text] [Related]
28. Is it Time to Perform Only Magnetic Resonance Imaging Targeted Cores? Our Experience with 1,032 Men Who Underwent Prostate Biopsy. Pepe P; Garufi A; Priolo GD; Galia A; Fraggetta F; Pennisi M J Urol; 2018 Oct; 200(4):774-778. PubMed ID: 29679618 [TBL] [Abstract][Full Text] [Related]
29. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy. Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694 [TBL] [Abstract][Full Text] [Related]
30. Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate. Ullrich T; Quentin M; Arsov C; Schmaltz AK; Tschischka A; Laqua N; Hiester A; Blondin D; Rabenalt R; Albers P; Antoch G; Schimmöller L J Urol; 2018 Mar; 199(3):691-698. PubMed ID: 28941924 [TBL] [Abstract][Full Text] [Related]
31. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. Vourganti S; Rastinehad A; Yerram N; Nix J; Volkin D; Hoang A; Turkbey B; Gupta GN; Kruecker J; Linehan WM; Choyke PL; Wood BJ; Pinto PA J Urol; 2012 Dec; 188(6):2152-2157. PubMed ID: 23083875 [TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan. Yamada Y; Fujihara A; Shiraishi T; Ueda T; Yamada T; Ueno A; Inoue Y; Kaneko M; Kamoi K; Hongo F; Okihara K; Ukimura O Int J Urol; 2019 May; 26(5):544-549. PubMed ID: 30793385 [TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis. Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418 [TBL] [Abstract][Full Text] [Related]
34. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy. Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717 [TBL] [Abstract][Full Text] [Related]